Impact of Institutional Expected Practice Guidelines on Oral and Long-acting Intravenous Antibiotic Use for Serious Bacterial Infections
Year: 2026
Type: article
Abstract: Background: Expected practice interventions are a low resource antimicrobial stewardship strategy to standardize prescribing behavior by clinicians. An expected practice intervention to encourage use of oral and long-acting IV (PO/LAIV) antibiotics for serious infections was implemented at a US tertiary care hospital in November of 2022. Methods: We conducted a quasi-experimental pre/post study to evaluate the effect of guideline release on a primary outcome of length of stay (LOS) and secondary outcomes of inpatient antibiotic days, 3-month readmission, PO/LAIV antibiotic use, microbiologic failure, and adverse drug events. We also assessed key factors associated with use of PO/LAIV therapy receipt. Results: = .03). On multivariable analysis, LOS did not differ (adjusted rate ratio [aRR] 0.91; 95% CI, .74-1.13), nor did inpatient intravenous antibiotic days (aRR 0.95; 95% CI, .78-1.16). Post-implementation encounters had lower odds of 3-month all cause readmission (adjusted odds ratio [aOR] 0.37; 95% CI, .17-.77) and higher odds of PO/LAIV use at discharge (aOR 2.77; 95% CI, 1.28-5.99). Conclusions: Expected practice intervention implementation was associated with an increase in PO/LAIV therapy use and a reduction in readmission, supporting its role as a promising, low-resource antimicrobial stewardship strategy warranting further prospective evaluation.
Source: Open Forum Infectious Diseases
DOI: 10.1093/ofid/ofag396
Institutions: University of Alabama at Birmingham, UAB Medicine
Language: English
Subfield: Applied Microbiology and Biotechnology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $4,053
OpenAlex ID: W7166827271
